is sitagliptin a glp-1 GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes Figure 2 from The incretin
Description
In marketing parlance, the customer journey more resembles a flywheel, rather than a funnel
In this context, GLP-1 RAs emerge as the target for therapeutical treatment for AD
In a model of lipopolysaccharide (LPS)-induced visceral hypersensitivity and repeated water avoidance stress (WAS) in rats, liraglutide effectively reduced visceral allodynia by suppressing pro-inflammatory cytokine production and improving colonic barrier integrity [59]
The expected timeline for patent expiration: The long patent timelines reflect layered intellectual property: composition-of-matter patents, formulation patents, manufacturing process patents, and dosing regimen patents
December 1, 2025
